Sunitinib nei feocromocitomi e paragangliomi

NEIL 1 ( nei endonuclease VIII - like 1 ( E . coli ) )

La riqualificazione energetica dell’edilizia sociale nei contesti italiano e olandese

In the context of a Post-Doc Research, still in progress (1), renovation of housing built from 1946 to 1970 in Europe has been individualized as a field of research. As a matter of fact it presents, among other issues, high energy consumption and low indoor air quality. Through an analytical comparison between two very different contexts, Italy and the Netherlands, the definition of two tools ̶ ...

Investigation of Z-E Isomerism in Sunitinib Anticancer drug

Accepted on 8 th April 2014 _____________________________________________________________________________ ABSTRACT Z-E isomerization in sunitinib, an important anticancer drug, has been investigated. The influence of light, heat and solvent was studied and the isomerizations were monitored by HPLC. As expected, the extent of Z-E isomerization (conversion of the Z-isomer into the undesired E-iso...

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...

Sunitinib Induced Immune Thrombocytopenia

Sunitinib is an oral tyrosine kinase inhibitor which prevents tumor growth and metastatic progression. It was approved for treatment of advanced renal cell cancer, gastrointestinal stromal tumor and advanced pancreatic neuroendocrine tumors. It has several adverse reactions on multi organ systems including hematologic system. Although the neutropenia and thrombocytopenia commonly happens as Gra...